Treatment Variations in Cerebral Venous Thrombosis: An International Survey

Abstract

patients in last 5 years. Ninety-two percent considered heparin the standard therapy for CVT and 87% did not regard intracranial hemorrhage a contraindication for commencing heparin therapy ( fig. Sixty-four percent reported using UFH and 36% LMWH. Eight percent of the respondents prescribed prophylactic AED in all patients and 21% only in patients with focal cerebral lesions. The remaining 71% never prescribed prophylactic AED. With regard to long-term antithrombotic therapy, 81% stated that they prescribe oral anticoagulants in all patients, unless there is an absolute contraindication. The duration of treatment varied: 13% usually treat for 3 months, 64% for 6 months and 20% for 1 year.